8 November 2020
Free Media Partnership between AI-ML Drug Discovery Summit 2021 and Applied System Innovation Journal
![](https://pub.mdpi-res.com/announcement/2266.jpg?1721979229)
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that AI-ML Drug Discovery Summit 2021 has set up a free media partnership with ASI.
The AI-ML: Drug Discovery Summit is the industry’s definitive guide to translating the wealth of tech available to successfully implement a working and practically effective drug discovery and development platform.
Designed with leading AI experts from R&D and clinical departments across big pharma, biotech, and academia, this year’s forum features 3 days of real-world case studies and interactive discussions. As such, the 2021 AI-ML Summit will provide you with a roadmap to augmented R&D and clinical decision making with reduced failure rates, increased speed, and improved margins.
This is a critical time for drug developers to make more data-driven decisions, and at the 4th AI-ML: Drug Discovery Summit you will learn how to strategically leverage AI technology to transform your pipelines, and patient’s lives.
Join 80+ like-minded peers who are overhauling outdated R&D and clinical processes to reflect on both successes and failures, and importantly the lessons learned along the way from the last year of implementation and utilization.